ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,147,883 | -61.4% | 1,771,279 | -45.8% | 0.01% | -50.0% |
| Q2 2023 | $21,108,812 | +185700.7% | 3,267,618 | +116.9% | 0.01% | +66.7% |
| Q1 2023 | $11,361 | +90.6% | 1,506,698 | +156.0% | 0.01% | +100.0% |
| Q4 2022 | $5,961 | -99.9% | 588,448 | -49.7% | 0.00% | -57.1% |
| Q3 2022 | $11,564,000 | -66.6% | 1,169,304 | -64.1% | 0.01% | -68.2% |
| Q2 2022 | $34,653,000 | +137.9% | 3,253,844 | +117.8% | 0.02% | +175.0% |
| Q1 2022 | $14,566,000 | +46.3% | 1,493,996 | +114.5% | 0.01% | +60.0% |
| Q4 2021 | $9,958,000 | -41.4% | 696,361 | -17.9% | 0.01% | -50.0% |
| Q3 2021 | $16,990,000 | +1076.6% | 847,819 | +1191.3% | 0.01% | +900.0% |
| Q2 2021 | $1,444,000 | +74.4% | 65,657 | +169.2% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -78.7% | 24,388 | -74.7% | 0.00% | -66.7% |
| Q4 2020 | $3,885,000 | – | 96,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |